Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Med Oncol ; 40(11): 311, 2023 Sep 29.
Article in English | MEDLINE | ID: mdl-37775552

ABSTRACT

Cancer has currently become a serious public health issue in many countries worldwide, and tumors of the digestive system have attracted an increasing number of researchers' due to their numerous types, high proportion and wide area of occurrence. While tumors of the digestive system suffer from high mortality rates, leading to untimely diagnosis and a poor prognosis, making it necessary to update current treatment approaches such as surgery, radiation therapy, and chemotherapy. This highlights the importance of exploring novel therapeutic ideas and targets. Traditional Chinese medicine has a long history of clinical use due to its low toxicity and multi-factor targeting of multiple pathways. As a kind of traditional Chinese herb, S. nigrum Linn. is highly regarded for its proven antitumor activity. The aim of this study was to comprehensively recapitulate and analyze the anti-cancer effects and molecular mechanisms of treatment of gastrointestinal tumors with S. nigrum Linn. extracts and related compounds, including classical signaling pathways mediated by them as well as noncoding RNA pathways associated with tumor suppression. Components that have been found to be responsible for the anti-cancer activity of S. nigrum Linn. include solanine, solasonine, solamargine, a-L-rhhamnopyranose, uttroside B, degalactotigonin, glycoprotein, and other compounds. The underlying mechanisms of anti-cancer activity reflected in this study include apoptosis, cell cycle arrest, autophagy, anti-angiogenesis, suppression of metastasis and invasion, immune escape, and increased sensitivity to radiotherapy. S. nigrum Linn. has great potential in the treatment of tumors of the digestive system, and through further clinical trials and pharmacological mechanisms it has the potential to become a uniform and standardized anti-tumor drug.


Subject(s)
Antineoplastic Agents, Phytogenic , Antineoplastic Agents , Digestive System Neoplasms , Gastrointestinal Neoplasms , Solanum nigrum , Humans , Antineoplastic Agents, Phytogenic/pharmacology , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Plant Extracts/pharmacology , Plant Extracts/therapeutic use
2.
Pathol Res Pract ; 244: 154382, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36868095

ABSTRACT

The digestive system malignant tumors (DSMTs), mainly consist of digestive tract and digestive gland tumors, become an inescapable culprit to hazard human health worldwide. Due to the huge hysteresis in the cognitive theories of DSMTs occurrence and progression, advances in medical technology have not improved the prognosis. Therefore, more studies on a variety of tumor-associated molecular biomarkers and more detailed disclosure on potential regulatory networks are urgently needed to facilitate the diagnostic and therapeutic strategies of DSMTs. With the development of cancer bioinformatics, a special type of endogenous RNA involved in multi-level cellular function regulation rather than encoding protein, is categorized as non-coding RNAs (ncRNAs) and becomes a hotspot issue in oncology. Among them, long non-coding RNAs (lncRNAs), transcription length > 200 nt, show obvious superiority in both research quantity and dimension compared to microRNAs (miRNAs) and circular RNAs (circRNAs). As a recently discovered lncRNA, LINC00511 has been confirmed to be closely associated with DSMTs and might be exploited as a novel biomarker. In the present review, the comprehensive studies of LINC00511 in DSMTs are summarized, as well as the underlying molecular regulatory networks. In addition, deficiencies in researches are point out and discussed. The Cumulative oncology studies provide a fully credible theoretical basis for identifying the regulatory role of LINC00511 in human DSMTs. LINC00511, proved to be an oncogene in DSMTs, might be defined as a potential biomarker for diagnosis and prognosis evaluation, as well as a rare therapeutic target.


Subject(s)
Digestive System Neoplasms , Gastrointestinal Neoplasms , MicroRNAs , RNA, Long Noncoding , Humans , Cell Line, Tumor , Cell Proliferation/genetics , MicroRNAs/genetics , Gastrointestinal Neoplasms/genetics , Digestive System Neoplasms/diagnosis , Digestive System Neoplasms/genetics , Digestive System Neoplasms/therapy , Biomarkers, Tumor/genetics , Digestive System/metabolism , RNA, Long Noncoding/genetics , RNA, Long Noncoding/metabolism , Gene Expression Regulation, Neoplastic
3.
Opt Express ; 30(4): 6374-6387, 2022 Feb 14.
Article in English | MEDLINE | ID: mdl-35209577

ABSTRACT

The misalignment error of the pumping laser in the atomic comagnetometer (ACM) dramatically diminishes the efficiency of the optical pumping process (characterized by the polarization of the hybrid atomic spin ensembles containing electron spins and nuclear spins) and deteriorates the performance of the ACM (characterized by the Allan standard deviation). In this work, a steady-state response model considering the misalignment error of the pumping laser is established and an in-situ evaluation method for this error is proposed. Based on the evaluation method, the influence of this misalignment error on the pumping efficiency and the performance of the ACM is quantitatively analyzed. Furthermore, a pumping laser alignment method based on the second harmonic of a single-beam magnetometer is then proposed, whose effectiveness is verified by experiments. The experimental results show that compared to the original ACM with the severely misaligned pumping laser, the polarization of the hybrid atomic spin ensembles of the ACM with the pumping laser aligned by the proposed method is increased by about 19%, and the corresponding Allan variance at 100s is reduced by about 40%.

SELECTION OF CITATIONS
SEARCH DETAIL
...